Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P53 and DNA damage-regulated protein 1 pseudogene (LOC101059974, ENSG00000257855) is a human processed pseudogene related to genes induced by p53-dependent DNA damage response. Pseudogenes like this arise from duplication or retrotransposition events in the genome and do not encode functional proteins. However, growing evidence suggests that some pseudogenes may have regulatory functions, such as being transcribed into noncoding RNA that can modulate the expression of their parental genes, sometimes affecting tumor suppressor or oncogene networks by serving as microRNA decoys or being processed into regulatory small RNAs[2][4][3]. For most pseudogenes, including this one, there is currently no evidence of direct pharmaceutical targeting or clinical utility beyond emerging research roles in RNA-mediated gene regulation. This is not a typical therapeutic target (such as a protein, enzyme, or receptor), and most curated drug and biomarker databases do not list pseudogenes as primary targets. No direct drugs, clinical biomarkers, or safety data are associated with this locus. It should not be considered a canonical drug target[3][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P53 and DNA damage-regulated protein 1 pseudogene (null).